Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 210

1.

Efficacy and safety of extended-duration inpatient-to-outpatient rabbit antithymocyte globulin induction in de novo kidney transplant recipients: 6-month outcomes.

Trofe-Clark J, Reese PP, Patel HJ, Jakobowski D, Goral S, Doll SL, Abt PL, Bloom RD.

Transplantation. 2012 Sep 15;94(5):506-12.

PMID:
22895613
2.

Evaluating safety and efficacy of rabbit antithymocyte globulin induction in elderly kidney transplant recipients.

Khanmoradi K, Knorr JP, Feyssa EL, Parsikia A, Jawa P, Dinh DB, Campos S, Zaki RF, Ortiz JA.

Exp Clin Transplant. 2013 Jun;11(3):222-8. doi: 10.6002/ect.2012.0211. Epub 2013 Feb 22.

3.

Clinical and economic analysis of delayed administration of antithymocyte globulin for induction therapy in kidney transplantation.

McGillicuddy JW, Taber DJ, Pilch NA, Kohout RK, Bratton CF, Chavin KD, Baliga PK.

Prog Transplant. 2013 Mar;23(1):33-8. doi: 10.7182/pit2013817.

PMID:
23448818
4.

Impact of small variations in the delivered dose of rabbit antithymocyte induction therapy in kidney transplantation with early corticosteroid withdrawal.

Tsapepas DS, Mohan S, Tanriover B, Dube G, Crew RJ, Cohen DJ, Hardy MA, Sandoval PR, Ratner LE.

Transplantation. 2012 Aug 27;94(4):325-30. doi: 10.1097/TP.0b013e318257ad1a.

PMID:
22814328
5.

Clinical and economic outcomes of rabbit antithymocyte globulin induction in adults who received kidney transplants from living unrelated donors and received cyclosporine-based immunosuppression.

Miller JT, Collins CD, Stuckey LJ, Luan FL, Englesbe MJ, Magee JC, Park JM.

Pharmacotherapy. 2009 Oct;29(10):1166-74. doi: 10.1592/phco.29.10.1166.

PMID:
19792990
6.

Reduced dose rabbit anti-thymocyte globulin induction for prevention of acute rejection in high-risk kidney transplant recipients.

Klem P, Cooper JE, Weiss AS, Gralla J, Owen P, Chan L, Wiseman AC.

Transplantation. 2009 Oct 15;88(7):891-6. doi: 10.1097/TP.0b013e3181b6f38c.

PMID:
19935460
7.

Clinical and economic analysis of short-course versus standard-course antithymocyte globulin (rabbit) induction therapy in deceased-donor renal transplant recipients.

Marfo K, Akalin E, Wang C, Lu A.

Am J Health Syst Pharm. 2011 Dec 1;68(23):2276-82. doi: 10.2146/ajhp110120.

PMID:
22095818
8.

A randomized 2×2 factorial trial, part 1: single-dose rabbit antithymocyte globulin induction may improve renal transplantation outcomes.

Stevens RB, Foster KW, Miles CD, Lane JT, Kalil AC, Florescu DF, Sandoz JP, Rigley TH, Nielsen KJ, Skorupa JY, Kellogg AM, Malik T, Wrenshall LE.

Transplantation. 2015 Jan;99(1):197-209. doi: 10.1097/TP.0000000000000250.

10.

Administration of rabbit antithymocyte globulin (thymoglobulin) in ambulatory renal-transplant patients.

Marvin MR, Droogan C, Sawinski D, Cohen DJ, Hardy MA.

Transplantation. 2003 Feb 27;75(4):488-9.

PMID:
12605115
11.

Rabbit antithymocyte induction and dosing in deceased donor renal transplant recipients over 60 yr of age.

Patel SJ, Knight RJ, Suki WN, Abdellatif A, Duhart BT Jr, Krauss AG, Mannan S, Nezakatgoo N, Osama Gaber A.

Clin Transplant. 2011 May-Jun;25(3):E250-6. doi: 10.1111/j.1399-0012.2010.01393.x. Epub 2011 Jan 13.

PMID:
21231963
12.

5-year results of a prospective, randomized, single-center study of alemtuzumab compared with rabbit antithymocyte globulin induction in simultaneous kidney-pancreas transplantation.

Stratta RJ, Rogers J, Orlando G, Farooq U, Al-Shraideh Y, Farney AC.

Transplant Proc. 2014 Jul-Aug;46(6):1928-31. doi: 10.1016/j.transproceed.2014.05.080.

PMID:
25131073
13.

Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.

Mai ML, Ahsan N, Wadei HM, Genco PV, Geiger XJ, Willingham DL, Taner CB, Hewitt WR, Grewal HP, Nguyen JH, Hughes CB, Gonwa TA.

Transplantation. 2009 Jan 27;87(2):227-32. doi: 10.1097/TP.0b013e31818c962b.

PMID:
19155977
14.

Comparison of clinical outcome of low-dose and high-dose rabbit antithymocyte globulin induction therapy in renal transplantation: a single-center experience.

Yang JW, Wang JN, Men TY, Zhang XM, Li XD, Shen B, Li GY, Chen DD.

Ann Transplant. 2014 Jun 6;19:277-82. doi: 10.12659/AOT.890069.

15.

Evaluation of a Weight-based Rabbit Anti-thymocyte Globulin Induction Dosing Regimen for Kidney Transplant Recipients.

Pennington CA, Tischer SM, Lee E, Lee S, Sindelar J Jr, Park JM.

Pharmacotherapy. 2015 Aug;35(8):748-54. doi: 10.1002/phar.1624. Epub 2015 Aug 3.

16.

Renal transplantation in the setting of early steroid withdrawal: a comparison of rabbit antithymocyte globulin induction dosing in two eras.

Rogers CC, Asipenko N, Horwedel T, Gautam S, Goldfarb-Rumyantzev AS, Pavlakis M, Johnson SR, Karp SJ, Evenson A, Khwaja K, Hanto DW, Mandelbrot DA.

Am J Nephrol. 2013;38(5):397-404. doi: 10.1159/000355620. Epub 2013 Oct 26.

PMID:
24192457
17.

A randomized trial of alemtuzumab versus antithymocyte globulin induction in renal and pancreas transplantation.

Farney AC, Doares W, Rogers J, Singh R, Hartmann E, Hart L, Ashcraft E, Reeves-Daniels A, Gautreaux M, Iskandar SS, Moore P, Adams PL, Stratta RJ.

Transplantation. 2009 Sep 27;88(6):810-9. doi: 10.1097/TP.0b013e3181b4acfb.

PMID:
19920781
18.

Randomized trial of single-dose versus divided-dose rabbit anti-thymocyte globulin induction in renal transplantation: an interim report.

Stevens RB, Mercer DF, Grant WJ, Freifeld AG, Lane JT, Groggel GC, Rigley TH, Nielsen KJ, Henning ME, Skorupa JY, Skorupa AJ, Christensen KA, Sandoz JP, Kellogg AM, Langnas AN, Wrenshall LE.

Transplantation. 2008 May 27;85(10):1391-9. doi: 10.1097/TP.0b013e3181722fad.

PMID:
18497677
19.

Low-dose thymoglobulin use in elderly renal transplant recipients is safe and effective induction therapy.

Laftavi MR, Patel S, Soliman MR, Alnimri M, Kohli R, Said M, Pankewycz O.

Transplant Proc. 2011 Mar;43(2):466-8. doi: 10.1016/j.transproceed.2011.01.039.

PMID:
21440735
20.

Prospective randomized controlled trial of rabbit antithymocyte globulin compared with IL-2 receptor antagonist induction therapy in kidney transplantation.

Pilch NA, Taber DJ, Moussa O, Thomas B, Denmark S, Meadows HB, McGillicuddy JW, Srinivas TR, Baliga PK, Chavin KD.

Ann Surg. 2014 May;259(5):888-93. doi: 10.1097/SLA.0000000000000496.

PMID:
24513787

Supplemental Content

Support Center